$1.7B Centocor Patent Award Against Abbott Stands

Law360, New York (November 5, 2009, 6:47 PM EST) -- A federal judge has upheld a jury verdict awarding Johnson & Johnson subsidiary Centocor Ortho Biotech Inc. and New York University a record $1.67 billion for their claims that Abbott Laboratories' flagship arthritis drug Humira infringed their patent.

In denying Abbott's post-trial bid to overturn the largest patent verdict in U.S. history, Judge T. John Ward of the U.S. District Court for the Eastern District of Texas ruled Wednesday that the drugmaker had failed to prove “by clear and convincing evidence that U.S. Patent Number 7,070,775...
To view the full article, register now.